Australien - engelsk - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - clobetasone butyrate, quantity: 0.5 mg/g - cream - excipient ingredients: citric acid monohydrate; chlorocresol; purified water; glycerol; cetostearyl alcohol; glyceryl monostearate; sodium citrate dihydrate; peg-100 stearate; stearic acid; carnauba wax; hard paraffin - short-term (up to 7 days) treatment of milder forms of eczema, dermatitis and other steroid responsive skin conditions.

Indien - engelsk - Central Drugs Standard Control Organization

gsk - clobetasone-17 butyrate,miconazole nit. - crm - 0.05,2;%;w/w - 15g

Indien - engelsk - Central Drugs Standard Control Organization

ind-swift - clobetasone-17 butyrate,gentamicin,miconazole nit.,iodochlorhydroxyquin - crm - 0.005,0.1,2,1;% - 5g/10g

Bahrain - engelsk - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

hamad town pharmacy - clobetasone 17-butyrate - ointment - 0.5

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - clobetasone butyrate; oxytetracycline calcium; nystatin - cutaneous cream - 500microgram/1gram ; 30mg/1gram ; 100000unit/1gram

Malta - engelsk - Medicines Authority

glaxo wellcome uk limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - clobetasone butyrate - ointment - clobetasone butyrate 0.05 % (w/w) - corticosteroids, dermatological preparations

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - clobetasone butyrate - cutaneous ointment - 500microgram/1gram

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - clobetasone butyrate 0.05%{relative};   - topical cream - 0.05% w/w - active: clobetasone butyrate 0.05%{relative}   excipient: beeswax, synthetic cetostearyl alcohol chlorocresol citric acid monohydrate dimeticone glycerol glyceryl monostearate purified water self-emulsifying glyceryl monostearate sodium citrate dihydrate - short-term (up to 7 days) treatment of milder forms of eczema and dermatitis.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - clobetasone butyrate 0.05%{relative};   - topical cream - 0.05% w/w - active: clobetasone butyrate 0.05%{relative}   excipient: beeswax, synthetic cetostearyl alcohol chlorocresol citric acid monohydrate dimeticone glycerol glyceryl monostearate purified water self-emulsifying glyceryl monostearate sodium citrate dihydrate - treatment of atopic eczema, photodermatitis, otitis externa, primary irritant and allergic dermatitis, prurigo nodularis, sevorrhoeic dermatitis, and other steroid responsive skin conditions which do not require the use of a more active topical corticosteroid in children and adults. in the more resistant dermatoses. eumovate may be used as maintenance therapy between courses of one of the more active topical steroids.

Israel - engelsk - Ministry of Health

glaxo smith kline (israel) ltd - clobetasone butyrate - ointment - clobetasone butyrate 0.05 %w/w - clobetasone - clobetasone - eumovate ointment is a moderately potent topical corticosteroid indicated for adults, elderly, children and infants for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.these include the following:- atopic dermatitis- irritant or allergic contact dermatitis- seborrhoeic dermatitis- nappy rash- photodermatitis- otitis externa- prurigo nodularis- insect bite reactionseumovate may be used as maintenance therapy between courses of one of the more potent topical steroids.